Cite
Resolvin E1 protects against doxorubicin-induced cardiotoxicity by inhibiting oxidative stress, autophagy and apoptosis by targeting AKT/mTOR signaling.
MLA
Zhang, Jishou, et al. “Resolvin E1 Protects against Doxorubicin-Induced Cardiotoxicity by Inhibiting Oxidative Stress, Autophagy and Apoptosis by Targeting AKT/MTOR Signaling.” Biochemical Pharmacology, vol. 180, Oct. 2020, p. N.PAG. EBSCOhost, https://doi.org/10.1016/j.bcp.2020.114188.
APA
Zhang, J., Wang, M., Ding, W., Zhao, M., Ye, J., Xu, Y., Wang, Z., Ye, D., Li, D., Liu, J., & Wan, J. (2020). Resolvin E1 protects against doxorubicin-induced cardiotoxicity by inhibiting oxidative stress, autophagy and apoptosis by targeting AKT/mTOR signaling. Biochemical Pharmacology, 180, N.PAG. https://doi.org/10.1016/j.bcp.2020.114188
Chicago
Zhang, Jishou, Menglong Wang, Wen Ding, Mengmeng Zhao, Jing Ye, Yao Xu, Zhen Wang, et al. 2020. “Resolvin E1 Protects against Doxorubicin-Induced Cardiotoxicity by Inhibiting Oxidative Stress, Autophagy and Apoptosis by Targeting AKT/MTOR Signaling.” Biochemical Pharmacology 180 (October): N.PAG. doi:10.1016/j.bcp.2020.114188.